Literature DB >> 18624259

Cascade screening in BRCA1/2 mutation carriers.

N Cody1, A Green, T McDevitt, S A Lynch.   

Abstract

Genetic counselling for families with BRCA1 & 2 has been available in Ireland since 1998. We describe the follow-on cascade from the initial 29 index cases that tested positive for either gene. 28 of the index cases were female and 1 was male. Their combined sibship and offspring totalled 125 and 129 respectively. Of the 125 siblings, 21/72 (29%) females and 10/53 (19%) males came forward for counselling and all were tested. Of the 129 at risk offspring, 56 (43%) [25 females and 31 males] were over 18 years and therefore were eligible for testing. 20/25 (80%) females and 6/31 (19%) males came for counselling and all bar one female was tested. In summary, 31/125 (25%) at risk siblings were tested and 25/56 (45%) offspring were tested. Only one person, a daughter of an affected individual who attended clinic, declined testing. The remaining 197 (77%) individuals have not come forward for counselling. Our results suggest that a) there is a low-moderate testing rate in Ireland when compared to other European centres; and that b) daughters of BRCA1/2 carriers are more likely to come forward for testing than female siblings. Specific factors which appeared to influence attendance included poor dissemination of information among families about the test; and lower levels of communication among siblings than within the nuclear family.

Entities:  

Mesh:

Year:  2008        PMID: 18624259

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  5 in total

1.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

2.  Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.

Authors:  Belinda J McClaren; Sylvia A Metcalfe; Maryanne Aitken; R John Massie; Obioha C Ukoumunne; David J Amor
Journal:  Eur J Hum Genet       Date:  2010-05-26       Impact factor: 4.246

3.  Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.

Authors:  David E O'Reilly; Lucy Dooley; Geoffrey A Watson; Roisin Clarke; Amy Nolan; Carmel Nolan; Eileen Berkeley; Michael Farrell; Trudi McDevitt; Melissa Rogers; Catherine Clabby; David J Gallagher
Journal:  Ir J Med Sci       Date:  2022-10-19       Impact factor: 2.089

4.  Dying to see you? Deaths on a clinical genetics waiting list in the Republic of Ireland; what are the consequences?

Authors:  Lisa Bradley; Sally Ann Lynch
Journal:  J Community Genet       Date:  2020-10-29

5.  Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.

Authors:  Stephen M Modell; Karen Greendale; Toby Citrin; Sharon L R Kardia
Journal:  Healthcare (Basel)       Date:  2016-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.